Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056499
Filing Date
2021-11-12
Accepted
2021-11-12 08:15:51
Documents
62
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dice-10q_20210930.htm   iXBRL 10-Q 3133734
2 EX-3.1 dice-ex31_384.htm EX-3.1 43553
3 EX-3.2 dice-ex32_383.htm EX-3.2 350549
4 EX-31.1 dice-ex311_157.htm EX-31.1 20422
5 EX-31.2 dice-ex312_156.htm EX-31.2 20474
6 EX-32.1 dice-ex321_159.htm EX-32.1 8576
7 EX-32.2 dice-ex322_158.htm EX-32.2 8727
  Complete submission text file 0001564590-21-056499.txt   9288745

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA dice-20210930.xsd EX-101.SCH 51279
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dice-20210930_cal.xml EX-101.CAL 45452
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dice-20210930_def.xml EX-101.DEF 222219
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE dice-20210930_lab.xml EX-101.LAB 420583
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dice-20210930_pre.xml EX-101.PRE 340057
13 EXTRACTED XBRL INSTANCE DOCUMENT dice-10q_20210930_htm.xml XML 1352503
Mailing Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080
Business Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filer) CIK: 0001645569 (see all company filings)

EIN.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40794 | Film No.: 211399833
SIC: 2834 Pharmaceutical Preparations